| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 08, 2026 |
Apogee Therapeutics Inc.
APGE
|
BUY |
$97.00
Est. +12%
|
$86.92 | $91.24 |
Pending
|
$88.33
+1.6%
|
| Jun 01, 2026 |
Gilead Sciences, Inc.
GILD
|
SELL |
$122.00
Est. +9%
|
$134.43 | $121.39 (Low) |
Bullseye Hit (±1%)
|
$125.59
+6.6%
|
| May 27, 2026 |
Biogen Inc
BIIB
|
BUY |
$227.00
Est. +18%
|
$193.08 | $203.45 |
Pending
|
$200.05
+3.6%
|
| May 05, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$543.00
Est. +26%
|
$429.85 | $456.68 |
Pending
|
$444.93
+3.5%
|
| Apr 30, 2026 |
Biogen Inc
BIIB
|
BUY |
$222.00
Est. +16%
|
$190.78 | $205.97 |
Pending
|
$200.05
+4.9%
|
| Mar 02, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$765.00
Est. +2%
|
$784.06 | $591.52 (Low) |
Target Met
|
$612.14
+21.9%
|
| Feb 26, 2026 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$108.00
Est. +18%
|
$91.87 | $95.90 |
Pending
|
$86.21
-6.2%
|
| Feb 24, 2026 |
Galapagos NV - ADR
GLPG
|
SELL |
$33.00
Est. +4%
|
$34.36 | $26.42 (Low) |
Target Met
|
$27.98
+18.6%
|
| Feb 20, 2026 |
PTC Therapeutics Inc
PTCT
|
BUY |
$82.00
Est. +21%
|
$67.95 | $79.91 |
Precision Hit (±3%)
|
$75.14
+10.6%
|
| Jan 27, 2026 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$745.00
Est. +3%
|
$769.05 | $591.52 (Low) |
Target Met
|
$612.14
+20.4%
|
| Jan 22, 2026 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$546.00
Est. +18%
|
$461.14 | $507.92 |
Pending
|
$444.93
-3.5%
|
| Nov 21, 2025 |
Contineum Therapeutics Inc. - Ordinary Shares - Class A
CTNM
|
BUY |
$22.00
Est. +80%
|
$12.22 | $16.33 |
Pending
|
$11.88
-2.8%
|
| Nov 04, 2025 |
Karyopharm Therapeutics Inc
KPTI
|
BUY |
$19.00
Est. +239%
|
$5.60 | $10.99 |
Pending
|
$9.50
+69.6%
|
| Oct 22, 2025 |
Galapagos NV - ADR
GLPG
|
SELL |
$28.00
Est. +11%
|
$31.43 | $26.42 (Low) |
Target Met
|
$27.98
+11.0%
|
| Sep 24, 2025 |
Cidara Therapeutics Inc
CDTX
|
BUY |
$137.00
Est. +55%
|
$88.58 | $221.42 |
Target Met
|
$221.38
+149.9%
|
| Sep 16, 2025 |
Kymera Therapeutics Inc
KYMR
|
BUY |
$70.00
Est. +45%
|
$48.27 | $103.00 |
Target Met
|
$86.21
+78.6%
|
| Sep 15, 2025 |
Atyr Pharma Inc
ATYR
|
BUY |
$1.50
Est. +47%
|
$1.02 | $1.37 |
Pending
|
$0.44
-56.8%
|
| Jun 25, 2025 |
Biogen Inc
BIIB
|
BUY |
$213.00
Est. +67%
|
$127.31 | $205.97 |
Pending
|
$200.05
+57.1%
|
| Jun 17, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$420.00
Est. +5%
|
$441.99 | $362.50 (Low) |
Target Met
|
$444.93
-0.7%
|
| Jan 10, 2025 |
IGM Biosciences Inc
IGMS
|
SELL |
$1.50
Est. +28%
|
$2.09 | $0.92 (Low) |
Target Met
|
$1.27
+39.2%
|
| Jan 07, 2025 |
Gilead Sciences, Inc.
GILD
|
SELL |
$83.00
Est. +8%
|
$90.63 | $88.58 (Low) |
Miss
|
$125.59
-38.6%
|
| Jan 07, 2025 |
Sage Therapeutics Inc
SAGE
|
SELL |
$5.00
Est. +16%
|
$5.98 | $5.45 (Low) |
Miss
|
$8.68
-45.2%
|
| Jan 07, 2025 |
PTC Therapeutics Inc
PTCT
|
BUY |
$58.00
Est. +30%
|
$44.61 | $87.23 |
Target Met
|
$75.14
+68.4%
|
| Jan 02, 2025 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$4.00
Est. +103%
|
$1.97 | $3.25 |
Miss
|
$1.78
-9.6%
|
| Dec 19, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$400.00
Est. +15%
|
$469.22 | $362.50 (Low) |
Target Met
|
$444.93
+5.2%
|
| Nov 29, 2024 |
Applied Therapeutics Inc
APLT
|
SELL |
$4.00
Est. +58%
|
$9.42 | $0.22 (Low) |
Target Met
|
$0.10
+98.9%
|
| Nov 20, 2024 |
Sage Therapeutics Inc
SAGE
|
SELL |
$4.00
Est. +19%
|
$4.91 | $4.62 (Low) |
Miss
|
$8.68
-76.8%
|
| Nov 05, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$451.00
Est. +10%
|
$499.88 | $362.50 (Low) |
Target Met
|
$444.93
+11.0%
|
| Oct 09, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$437.00
Est. +5%
|
$458.94 | $362.50 (Low) |
Target Met
|
$444.93
+3.1%
|
| Oct 01, 2024 |
IGM Biosciences Inc
IGMS
|
BUY |
$17.00
Est. +3%
|
$16.54 | $20.35 |
Target Met
|
$1.27
-92.3%
|
| Sep 09, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,282.00
Est. +13%
|
$1,139.41 | $1,170.58 |
Miss
|
$612.14
-46.3%
|
| Aug 29, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$136.00
Est. +10%
|
$123.76 | $154.61 |
Target Met
|
$159.76
+29.1%
|
| Aug 09, 2024 |
Gilead Sciences, Inc.
GILD
|
SELL |
$72.00
Est. +5%
|
$75.59 | $72.43 (Low) |
Bullseye Hit (±1%)
|
$125.59
-66.1%
|
| Aug 08, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$181.00
Est. +29%
|
$140.06 | $144.22 |
Miss
|
$15.31
-89.1%
|
| Aug 08, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$106.00
Est. +44%
|
$73.63 | $131.98 |
Target Met
|
$131.87
+79.1%
|
| Aug 06, 2024 |
89bio Inc
ETNB
|
BUY |
$12.00
Est. +49%
|
$8.03 | $11.84 |
Precision Hit (±3%)
|
$14.84
+84.8%
|
| Aug 02, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,240.00
Est. +13%
|
$1,093.14 | $1,211.20 |
Precision Hit (±3%)
|
$612.14
-44.0%
|
| Jul 31, 2024 |
Incyte Corp.
INCY
|
BUY |
$66.00
Est. +0%
|
$65.70 | $83.94 |
Target Met
|
$108.53
+65.2%
|
| Jul 29, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$182.00
Est. +23%
|
$147.88 | $150.48 |
Miss
|
$15.31
-89.6%
|
| Jul 26, 2024 |
Biogen Inc
BIIB
|
BUY |
$282.00
Est. +32%
|
$214.16 | $219.44 |
Miss
|
$200.05
-6.6%
|
| Jun 28, 2024 |
CVS Health Corp
CVS
|
BUY |
$74.00
Est. +26%
|
$58.58 | $72.51 |
Precision Hit (±3%)
|
$101.96
+74.1%
|
| Jun 18, 2024 |
Xenon Pharmaceuticals Inc
XENE
|
BUY |
$55.00
Est. +52%
|
$36.25 | $46.00 |
Miss
|
$52.10
+43.7%
|
| Jun 18, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$103.00
Est. +36%
|
$75.48 | $131.98 |
Target Met
|
$131.87
+74.7%
|
| Jun 17, 2024 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$29.00
Est. +199%
|
$9.71 | $17.19 |
Miss
|
$1.78
-81.7%
|
| Jun 14, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$74.00
Est. +14%
|
$64.68 | $119.69 |
Target Met
|
$125.59
+94.2%
|
| Jun 13, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,299.00
Est. +27%
|
$1,022.03 | $1,211.20 |
Miss
|
$612.14
-40.1%
|
| Jun 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,229.00
Est. +22%
|
$1,010.54 | $1,211.20 |
Precision Hit (±3%)
|
$612.14
-39.4%
|
| Jun 11, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
SELL |
$421.00
Est. +13%
|
$483.28 | $386.66 (Low) |
Target Met
|
$444.93
+7.9%
|
| Jun 11, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$82.00
Est. +87%
|
$43.87 | $61.90 |
Miss
|
$8.19
-81.3%
|
| Jun 10, 2024 |
Karyopharm Therapeutics Inc
KPTI
|
BUY |
$3.00
Est. +216%
|
$0.95 | $135.00 |
Target Met
|
$9.50
+900.0%
|
| Jun 06, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$141.00
Est. +5%
|
$133.69 | $157.98 |
Target Met
|
$159.76
+19.5%
|
| Jun 05, 2024 |
Mind Medicine Inc
MNMD
|
BUY |
$22.00
Est. +167%
|
$8.25 | $10.44 |
Miss
|
$20.69
+150.8%
|
| Jun 05, 2024 |
Definium Therapeutics, Inc.
DFTX
|
BUY |
$22.00
Est. +167%
|
$8.25 | - | - |
$24.75
+200.0%
|
| Jun 04, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,200.00
Est. +20%
|
$998.64 | $1,211.20 |
Bullseye Hit (±1%)
|
$612.14
-38.7%
|
| May 28, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$142.00
Est. +15%
|
$123.46 | $155.95 |
Target Met
|
$15.31
-87.6%
|
| May 20, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$157.00
Est. +20%
|
$130.70 | $155.95 |
Bullseye Hit (±1%)
|
$15.31
-88.3%
|
| May 20, 2024 |
Corbus Pharmaceuticals Holdings Inc
CRBP
|
BUY |
$77.00
Est. +71%
|
$45.00 | $61.90 |
Miss
|
$8.19
-81.8%
|
| May 09, 2024 |
IGM Biosciences Inc
IGMS
|
BUY |
$20.00
Est. +114%
|
$9.34 | $22.50 |
Target Met
|
$1.27
-86.4%
|
| May 07, 2024 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$424.00
Est. +5%
|
$402.50 | $519.88 |
Target Met
|
$444.93
+10.5%
|
| May 07, 2024 |
Intra-Cellular Therapies Inc
ITCI
|
BUY |
$96.00
Est. +35%
|
$71.21 | $131.98 |
Target Met
|
$131.87
+85.2%
|
| May 07, 2024 |
Pliant Therapeutics Inc
PLRX
|
BUY |
$45.00
Est. +226%
|
$13.79 | $16.07 |
Miss
|
$1.13
-91.8%
|
| May 03, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,185.00
Est. +26%
|
$937.61 | $1,211.20 |
Precision Hit (±3%)
|
$612.14
-34.7%
|
| May 02, 2024 |
Sarepta Therapeutics Inc
SRPT
|
BUY |
$141.00
Est. +8%
|
$130.90 | $155.95 |
Target Met
|
$15.31
-88.3%
|
| Apr 30, 2024 |
Contineum Therapeutics Inc. - Ordinary Shares - Class A
CTNM
|
BUY |
$30.00
Est. +88%
|
$16.00 | $21.92 |
Miss
|
$11.88
-25.7%
|
| Apr 25, 2024 |
Biogen Inc
BIIB
|
BUY |
$317.00
Est. +57%
|
$201.99 | $237.98 |
Miss
|
$200.05
-1.0%
|
| Apr 17, 2024 |
Sage Therapeutics Inc
SAGE
|
BUY |
$26.00
Est. +115%
|
$12.12 | $13.46 |
Miss
|
$8.68
-28.4%
|
| Apr 11, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,189.00
Est. +29%
|
$921.34 | $1,211.20 |
Precision Hit (±3%)
|
$612.14
-33.6%
|
| Mar 13, 2024 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$31.00
Est. +109%
|
$14.81 | $17.19 |
Miss
|
$1.78
-88.0%
|
| Feb 14, 2024 |
Gilead Sciences, Inc.
GILD
|
BUY |
$76.00
Est. +3%
|
$73.53 | $106.69 |
Target Met
|
$125.59
+70.8%
|
| Jan 12, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,076.00
Est. +15%
|
$933.20 | $1,211.20 |
Target Met
|
$612.14
-34.4%
|
| Oct 10, 2023 |
Neumora Therapeutics Inc.
NMRA
|
BUY |
$24.00
Est. +120%
|
$10.91 | $15.99 |
Miss
|
$1.78
-83.7%
|
| Sep 27, 2023 |
Gilead Sciences, Inc.
GILD
|
BUY |
$84.00
Est. +11%
|
$75.90 | $84.88 |
Precision Hit (±3%)
|
$125.59
+65.5%
|
| Jun 23, 2022 |
PTC Therapeutics Inc
PTCT
|
BUY |
$46.00
Est. +20%
|
$38.29 | - | - |
$75.14
+96.2%
|
| Apr 05, 2022 |
Biogen Inc
BIIB
|
BUY |
$244.00
Est. +18%
|
$207.61 | - | - |
$200.05
-3.6%
|
| Mar 10, 2022 |
Karyopharm Therapeutics Inc
KPTI
|
BUY |
$8.00
Est. +23%
|
$6.49 | $129.45 |
Target Met
|
$9.50
+46.4%
|
| Feb 24, 2022 |
Sage Therapeutics Inc
SAGE
|
BUY |
$37.00
Est. +7%
|
$34.71 | - | - |
$8.68
-75.0%
|